Temporal phacoemulsification, complications of temporal phacoemulsification, surgical outcome of temporal phacoemulsificationIntroduction: Temporal phacoemulsification (Phaco) gives a better surgical outcome in senile cataracts as it nullifies, "against the rule astigmatism" which is common in elderly patients. It is a wellestablished, effective and safe technique. We conducted this study to verify the surgical outcome of temporal phacoemulsification at a rural tertiary care hospital (RTCH).
Aims and Objectives:To study the intra operative and early postoperative complications, post-operative UCVA (Uncorrected Visual Acuity) and BCVA (Best Corrected Visual Acuity) in patients with senile cataract who underwent temporal phacoemulsification. Materials and Methods: In this prospective, hospital based observational study, we studied intraoperative and postoperative data of 42 patients, above 50 years of age, who underwent temporal phacoemulsification for senile cataract from August 2019 to May 2020 after obtaining institutional ethical committee approval and written informed consent from all patients. All patients underwent minimum 6 weeks of postoperative follow up. Results: Out of 42 patients, 57.14% were females and the most common age group was 61-70 years. Intraoperative bleeding was seen in 19.04% patients and post-operative mild corneal stromal haze and mild uveitis was seen in 4.76% and 7.14% patients on postoperative day 1(POD 1) respectively. Reduction in preoperative "against the rule astigmatism" was seen in 68% patients. All patients had an UCVA of >6/12 and a BCVA of 6/6 at last follow up. Conclusion: Temporal phacoemulsification gives a good UCVA and faster visual rehabilitation in patients with senile cataract.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.